In addition to neurodegenerative phenotypes, we also compared APOE gene expression between neuropsychiatric diseases (schizophrenia, bipolar disorders [BP], major depression disorders [MDD]), and controls in LIBD European and African individuals. This evidence concerns the gene APOE and bipolar disorder.